Find Research Outputs

Search concepts
Selected filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017

Author

  • Toshihiro Miyamoto
2017

Recurrent subcutaneous sweet’s disease in a myelofibrosis patient treated with ruxolitinib before allogeneic stem cell transplantation

Sakoda, T., Kanamitsu, Y., Mori, Y., Sasaki, K., Yonemitsu, E., Nagae, K., Yoshimoto, G., Kamezaki, K., Kato, K., Takenaka, K., Miyamoto, T., Furue, M., Iwasaki, H. & Akashi, K., Jan 1 2017, In : Internal Medicine. 56, 18, p. 2481-2485 5 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)
2019

Usefulness of medication instruction sheets for sharing information on cancer chemotherapy within the health care team

Uchida, M., Nakamura, T., Watanabe, H., Kato, K., Miyamoto, T., Akashi, K. & Masuda, S., Jan 1 2019, In : Pharmazie. 74, 9, p. 566-569 4 p.

Research output: Contribution to journalArticle

A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma

on behalf of the Japan Study Group for Cell Therapy and Transplantation (JSCT), Jan 22 2019, In : International journal of hematology. 109, 1, p. 107-114 8 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)

Risk of secondary primary malignancies in multiple myeloma patients with or without autologous stem cell transplantation

For the Fukuoka Blood and Marrow Transplantation Group, Jan 22 2019, In : International journal of hematology. 109, 1, p. 98-106 9 p.

Research output: Contribution to journalArticle

2018
1 Citation (Scopus)

Comparison of antiemetic effects of granisetron and palonosetron in patients receiving bendamustine-based chemotherapy

Uchida, M., Nakamura, T., Makihara, Y., Suetsugu, K., Ikesue, H., Mori, Y., Kato, K., Shiratsuchi, M., Hosohata, K., Miyamoto, T. & Akashi, K., Jan 1 2018, In : Pharmazie. 73, 5, p. 304-308 5 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)
2019

Evaluation of the compliance with antiemetic guidelines for prevention of chemotherapy-induced nausea and vomiting in patients with hematologic malignancy

Uchida, M., Nakamura, T., Shima, T., Mori, Y., Yoshimoto, G., Kato, K., Shimokawa, M., Hosohata, K., Miyamoto, T. & Akashi, K., Jan 1 2019, In : Pharmazie. 74, 4, p. 250-254 5 p.

Research output: Contribution to journalArticle

2017

Identification of unipotent megakaryocyte progenitors in human hematopoiesis

Miyawaki, K., Iwasaki, H., Jiromaru, T., Kusumoto, H., Yurino, A., Sugio, T., Uehara, Y., Odawara, J., Daitoku, S., Kunisaki, Y., Mori, Y., Arinobu, Y., Tsuzuki, H., Kikushige, Y., Iino, T., Kato, K., Takenaka, K., Miyamoto, T., Maeda, T. & Akashi, K., Jun 22 2017, In : Blood. 129, 25, p. 3332-3343 12 p.

Research output: Contribution to journalArticle

16 Citations (Scopus)
2018

Prospective randomization of post-remission therapy comparing autologous peripheral blood stem cell transplantation versus high-dose cytarabine consolidation for acute myelogenous leukemia in first remission

For the Japan Study Group for Cell Therapy and Transplantation (JSCT), Apr 1 2018, In : International journal of hematology. 107, 4, p. 468-477 10 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)
2019
2 Citations (Scopus)
2018
1 Citation (Scopus)
2019

Anti-GPRC5D/CD3 bispecific T-cell-redirecting antibody for the treatment of multiple myeloma

Kodama, T., Kochi, Y., Nakai, W., Mizuno, H., Baba, T., Habu, K., Sawada, N., Tsunoda, H., Shima, T., Miyawaki, K., Kikushige, Y., Mori, Y., Miyamoto, T., Maeda, T. & Akashi, K., Jan 1 2019, In : Molecular Cancer Therapeutics. 18, 9, p. 1555-1564 10 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Prophylactic antiemetics for haematological malignancies: Prospective nationwide survey subset analysis in Japan

Yoshida, I., Tamura, K., Miyamoto, T., Shimokawa, M., Takamatsu, Y., Nanya, Y., Matsumura, I., Gotoh, M., Igarashi, T., Takahashi, T., Aiba, K., Kumagai, K., Ishizawa, K., Kurita, N., Usui, N. & Hatake, K., Jan 1 2019, In : In Vivo. 33, 4, p. 1355-1362 8 p.

Research output: Contribution to journalArticle

Open Access
2017
3 Citations (Scopus)
2018
2019

Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained deep molecular responses for 2 years: a multicenter phase 2 trial, stop nilotinib (NILSt)

Nagafuji, K., Matsumura, I., Shimose, T., Kawaguchi, T., Kuroda, J., Nakamae, H., Miyamoto, T., Kadowaki, N., Ishikawa, J., Imamura, Y., Yamazaki, H., Akashi, K. & Kanakura, Y., Dec 1 2019, In : International journal of hematology. 110, 6, p. 675-682 8 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Impact of High-Frequency HLA Haplotypes on Clinical Cytomegalovirus Reactivation in Allogeneic Hematopoietic Stem Cell Transplantation

HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation, Jan 1 2019, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

2017

Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program

Medical Committee of Japan Marrow Donor Program, Japanese Data Center for Hematopoietic Cell Transplantation, Jun 2017, In : Biology of Blood and Marrow Transplantation. 23, 6, p. 938-944 7 p.

Research output: Contribution to journalArticle

20 Citations (Scopus)
2020

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for ATL with HTLV-1 Antibody-Positive Donors

ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation, Jan 1 2020, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

2017

Phase I study of glasdegib (PF-04449913), an oral smoothened inhibitor, in Japanese patients with select hematologic malignancies

Minami, Y., Minami, H., Miyamoto, T., Yoshimoto, G., Kobayashi, Y., Munakata, W., Onishi, Y., Kobayashi, M., Ikuta, M., Chan, G., Woolfson, A., Ono, C., Shaik, M. N., Fujii, Y., Zheng, X. & Naoe, T., Aug 2017, In : Cancer Science. 108, 8, p. 1628-1633 6 p.

Research output: Contribution to journalArticle

18 Citations (Scopus)
2018

Clinical profile of gilteritinib in Japanese patients with relapsed/refractory acute myeloid leukemia: An open-label phase 1 study

Usuki, K., Sakura, T., Kobayashi, Y., Miyamoto, T., Iida, H., Morita, S., Bahceci, E., Kaneko, M., Kusano, M., Yamada, S., Takeshita, S., Miyawaki, S. & Naoe, T., Oct 2018, In : Cancer Science. 109, 10, p. 3235-3244 10 p.

Research output: Contribution to journalArticle

9 Citations (Scopus)
2017

Persistent detection of alternatively spliced BCR-ABL variant results in a failure to achieve deep molecular response

Yuda, J., Miyamoto, T., Odawara, J., Ohkawa, Y., Semba, Y., Hayashi, M., Miyamura, K., Tanimoto, M., Yamamoto, K., Taniwaki, M. & Akashi, K., Nov 2017, In : Cancer Science. 108, 11, p. 2204-2212 9 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)
2018

Microenvironmental immune cell signatures dictate clinical outcomes for PTCL-NOS

Sugio, T., Miyawaki, K., Kato, K., Sasaki, K., Yamada, K., Iqbal, J., Miyamoto, T., Ohshima, K., Maeda, T., Miyoshi, H. & Akashi, K., Sep 11 2018, In : Blood Advances. 2, 17, p. 2242-2252 11 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)
2017

Analysis of the variable factors influencing tacrolimus blood concentration during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation

Suetsugu, K., Ikesue, H., Miyamoto, T., Shiratsuchi, M., Yamamoto-Taguchi, N., Tsuchiya, Y., Matsukawa, K., Uchida, M., Watanabe, H., Akashi, K. & Masuda, S., Mar 1 2017, In : International journal of hematology. 105, 3, p. 361-368 8 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)
2018

Efficacy and safety of switching to nilotinib in patients with CML-CP in major molecular response to imatinib: results of a multicenter phase II trial (NILSw trial)

Ishikawa, J., Matsumura, I., Kawaguchi, T., Kuroda, J., Nakamae, H., Miyamoto, T., Matsuoka, K. I., Shibayama, H., Hino, M., Hirase, C., Kamimura, T., Shimose, T., Akashi, K. & Kanakura, Y., May 1 2018, In : International journal of hematology. 107, 5, p. 535-540 6 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

A comparison of minimal residual disease detection in autografts among ASO-qPCR, droplet digital PCR, and next-generation sequencing in patients with multiple myeloma who underwent autologous stem cell transplantation

Takamatsu, H., Wee, R. K., Zaimoku, Y., Murata, R., Zheng, J., Moorhead, M., Carlton, V. E. H., Kong, K. A., Takezako, N., Ito, S., Miyamoto, T., Yokoyama, K., Matsue, K., Sato, T., Kurokawa, T., Yagi, H., Terasaki, Y., Ohata, K., Matsumoto, M., Yoshida, T. & 2 others, Faham, M. & Nakao, S., Nov 2018, In : British Journal of Haematology. 183, 4, p. 664-668 5 p.

Research output: Contribution to journalLetter

2 Citations (Scopus)

Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: A Nationwide Survey in Japan

Kawajiri-Manako, C., Sakaida, E., Ohwada, C., Miyamoto, T., Azuma, T., Taguchi, J., Mori, T., Hasegawa, Y., Kondo, T., Yujiri, T., Yoshimitsu, M., Imada, K., Kurahashi, S., Kahata, K., Ichinohe, T., Hirokawa, M., Atsuta, Y. & Nakaseko, C., Jun 2018, In : Biology of Blood and Marrow Transplantation. 24, 6, p. 1180-1186 7 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)

Plerixafor for mobilization and collection of haematopoietic stem cells for autologous transplantation in Japanese patients with non-Hodgkin lymphoma: a randomized phase 2 study

Matsue, K., Kumagai, K., Sugiura, I., Ishikawa, T., Igarashi, T., Sato, T., Uchiyama, M., Miyamoto, T., Ono, T., Ueda, Y., Kiguchi, T., Sunaga, Y., Sasaki, T. & Suzuki, K., Nov 1 2018, In : International journal of hematology. 108, 5, p. 524-534 11 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Correction to: Plerixafor for mobilization and collection of haematopoietic stem cells for autologous transplantation in Japanese patients with non-Hodgkin lymphoma: a randomized phase 2 study (International Journal of Hematology, (2018), 108, 5, (524-534), 10.1007/s12185-018-2505-4)

Matsue, K., Kumagai, K., Sugiura, I., Ishikawa, T., Igarashi, T., Sato, T., Uchiyama, M., Miyamoto, T., Ono, T., Ueda, Y., Kiguchi, T., Sunaga, Y., Sasaki, T. & Suzuki, K., Nov 1 2018, In : International journal of hematology. 108, 5, 1 p.

Research output: Contribution to journalComment/debate

2020

Low incidence of posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab

on behalf of the Complication Working Group of the Japan Society for Hematopoietic Cell Transplantation, Jan 1 2020, (Accepted/In press) In : Hematological Oncology.

Research output: Contribution to journalArticle

Autologous hematopoietic cell transplantation for acute myeloid leukemia in adults: 25 years of experience in Japan

Yanada, M., Takami, A., Mizuno, S., Mori, J., Chou, T., Usuki, K., Uchiyama, H., Amano, I., Fujii, S., Miyamoto, T., Saito, T., Kamimura, T., Ichinohe, T., Fukuda, T., Okamoto, S., Atsuta, Y. & Yano, S., Jan 1 2020, In : International journal of hematology. 111, 1, p. 93-102 10 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)
2018

Significance of Salvage Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma: A Nationwide Retrospective Study in Japan

Muta, T., Miyamoto, T., Kamimura, T., Kanda, Y., Nohgawa, M., Ueda, Y., Iwato, K., Sasaki, O., Mori, T., Uchida, N., Iida, S., Fukuda, T., Atsuta, Y. & Sunami, K., Feb 1 2018, In : Acta Haematologica. 139, 1, p. 35-44 10 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)
2017

Comparison of Autologous and Unrelated Transplants for Cytogenetically Normal Acute Myelogenous Leukemia

Mizutani, M., Takami, A., Hara, M., Mizuno, S., Yanada, M., Chou, T., Uchiyama, H., Ohashi, K., Miyamoto, T., Ozawa, Y., Imataki, O., Kobayashi, N., Uchida, N., Kanamori, H., Kamimura, T., Eto, T., Onizuka, M., Tanaka, J., Atsuta, Y. & Yano, S., Sep 2017, In : Biology of Blood and Marrow Transplantation. 23, 9, p. 1447-1454 8 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)
2019

Cytomegalovirus reactivation is associated with increased mortality more than 100 days after allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma

ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation, May 2019, In : American Journal of Hematology. 94, 5, p. E143-E146

Research output: Contribution to journalLetter

2 Citations (Scopus)

Bortezomib-based strategy with autologous stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for Cell Therapy and Transplantation (JSCT-MM12)

Sunami, K., Matsumoto, M., Fuchida, S. I., Omoto, E., Takamatsu, H., Adachi, Y., Choi, I., Fujishima, N., Kiguchi, T., Miyamoto, T., Maeda, A., Suzumiya, J., Yamamura, R., Nagafuji, K., Nakazato, T., Kuroda, Y., Yujiri, T., Takamatsu, Y., Harada, M. & Akashi, K., Jan 1 2019, In : International Journal of Clinical Oncology.

Research output: Contribution to journalArticle

2017

Prior history of HLA-mismatched stem cell transplantation is a risk factor for graft failure in HLA-haploidentical transplantation

Sugita, J., Miyamoto, T., Kawashima, N., Hatsumi, N., Anzai, N., Kaneko, H., Nara, M., Minauchi, K., Harada, M. & Teshima, T., Feb 1 2017, In : Bone Marrow Transplantation. 52, 2, p. 323-325 3 p.

Research output: Contribution to journalLetter

2019

Clinical Implications of t(11;14) in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

Takamatsu, H., Yamashita, T., Kurahashi, S., Saitoh, T., Kondo, T., Maeda, T., Nakazawa, H., Murata, M., Narita, T., Kuroda, J., Hashimoto, H., Kawamura, K., Miyamoto, T., Honda, S., Ichinohe, T., Atsuta, Y. & Sunami, K., Mar 2019, In : Biology of Blood and Marrow Transplantation. 25, 3, p. 474-479 6 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)
2020

Phase 1b/2 study of blinatumomab in Japanese adults with relapsed/refractory acute lymphoblastic leukemia

Kiyoi, H., Morris, J. D., Oh, I., Maeda, Y., Minami, H., Miyamoto, T., Sakura, T., Iida, H., Tuglus, C. A., Chen, Y., Dos Santos, C., Kalabus, J., Anderson, A., Hata, T., Nakashima, Y. & Kobayashi, Y., Jan 1 2020, (Accepted/In press) In : Cancer Science.

Research output: Contribution to journalArticle

Open Access

Increasing Diluent Volume Decreases Bendamustine-Induced Venous Irritation without Reducing the Therapeutic Efficacy

Ishida, S., Morikawa, H., Watanabe, H., Tsuji, T., Sugio, T., Mori, Y., Miyamoto, T., Masuda, S., Akashi, K. & Egashira, N., Jan 1 2020, In : Biological & pharmaceutical bulletin. 43, 3, p. 488-492 5 p.

Research output: Contribution to journalArticle

Open Access
2019

Prospective evaluation of minimal residual disease monitoring to predict prognosis of adult patients with Ph-negative acute lymphoblastic leukemia

Nagafuji, K., Miyamoto, T., Eto, T., Ogawa, R., Okumura, H., Takase, K., Kawano, N., Miyazaki, Y., Fujisaki, T., Wake, A., Ohno, Y., Kurokawa, T., Kamimura, T., Takamatsu, Y., Yokota, S. & Akashi, K., Jan 1 2019, In : European Journal of Haematology. 103, 3, p. 164-171 8 p.

Research output: Contribution to journalArticle

Previous exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantation

Mori, Y., Yoshimoto, G., Yuda, J. I., Hayashi, M., Odawara, J., Kuriyama, T., Sugio, T., Miyawaki, K., Kamezaki, K., Kato, K., Takenaka, K., Iwasaki, H., Maeda, T., Miyamoto, T. & Akashi, K., Jan 2 2019, In : Leukemia and Lymphoma. 60, 1, p. 271-273 3 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)
2017

Graft-versus-host disease targets ovary and causes female infertility in mice

Shimoji, S., Hashimoto, D., Tsujigiwa, H., Miyawaki, K., Kato, K., Takahashi, S., Ogasawara, R., Jiromaru, T., Iwasaki, H., Miyamoto, T., Akashi, K. & Teshima, T., Mar 2 2017, In : Blood. 129, 9, p. 1216-1225 10 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)

Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation

Takamatsu, H., Takezako, N., Zheng, J., Moorhead, M., Carlton, V. E. H., Kong, K. A., Murata, R., Ito, S., Miyamoto, T., Yokoyama, K., Matsue, K., Sato, T., Kurokawa, T., Yagi, H., Terasaki, Y., Ohata, K., Matsumoto, M., Yoshida, T., Faham, M. & Nakao, S., Jan 1 2017, In : Annals of Oncology. 28, 10, p. 2503-2510 8 p.

Research output: Contribution to journalArticle

17 Citations (Scopus)
2019
Open Access
2 Citations (Scopus)
2018

Successful treatment of Ph ALL with hematopoietic stem cell transplantation from the same HLA-haploidentical related donor of previous liver transplantation

Sasaki, K., Mori, Y., Yoshimoto, G., Sakoda, T., Kato, K., Inadomi, K., Kamezaki, K., Takenaka, K., Iwasaki, H., Maeda, T., Miyamoto, T. & Akashi, K., Aug 3 2018, In : Leukemia and Lymphoma. 59, 8, p. 2005-2007 3 p.

Research output: Contribution to journalEditorial

1 Citation (Scopus)
2019

Safety and Seropositivity after Live Attenuated Vaccine in Adult Patients Receiving Hematopoietic Stem Cell Transplantation

Aoki, T., Kamimura, T., Yoshida, S., Mori, Y., Kadowaki, M., Kohno, K., Ishihara, D., Urata, S., Sugio, T., Kamezaki, K., Kato, K., Ito, Y., Eto, T., Akashi, K. & Miyamoto, T., Aug 2019, In : Biology of Blood and Marrow Transplantation. 25, 8, p. 1576-1585 10 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Comparison of calcineurin inhibitors in combination with conventional methotrexate, reduced methotrexate, or mycophenolate mofetil for prophylaxis of graft-versus-host disease after umbilical cord blood transplantation

Yoshida, S., Ohno, Y., Nagafuji, K., Yoshimoto, G., Sugio, T., Kamimura, T., Ohta, T., Takase, K., Henzan, H., Muta, T., Iwasaki, H., Ogawa, R., Eto, T., Akashi, K. & Miyamoto, T., Nov 1 2019, In : Annals of Hematology. 98, 11, p. 2579-2591 13 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)
2017

Comparative analysis of pulmonary hypertension in patients treated with imatinib, nilotinib and dasatinib

Minami, M., Arita, T., Iwasaki, H., Muta, T., Aoki, T., Aoki, K., Yamasaki, S., Matsushima, T., Kato, K., Takenaka, K., Tanimoto, K., Kamimura, T., Ogawa, R., Akashi, K. & Miyamoto, T., May 2017, In : British Journal of Haematology. 177, 4, p. 578-587 10 p.

Research output: Contribution to journalArticle

10 Citations (Scopus)
2020

Phase I/II study of bortezomib, lenalidomide, and dexamethasone treatment for relapsed and refractory multiple myeloma

Fukuoka Blood and Marrow Transplantation Group, Jan 1 2020, (Accepted/In press) In : International journal of hematology.

Research output: Contribution to journalArticle